The B7 Homologues and their Receptors in Hematologic Malignancies

Ryan A. Wilcox, Stephen Maxted Ansell, Megan S. Lim, Weiping Zou, Lieping Chen

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The B7 homologues and their receptors regulate both peripheral tolerance and adaptive immunity. This field is rapidly evolving as new ligands and receptors are being identified. Much of the work supporting their role in the regulation of host anti-tumor immunity has been derived from experimental models and clinical trials in solid malignancies. However, a growing body of evidence demonstrates that the B7-H family has important immunologic and non-immunologic functions in a variety of hematologic malignancies. Herein, we will review recent evidence that supports the therapeutic targeting of the B7 homologues in hematologic malignancies.

Original languageEnglish (US)
Pages (from-to)465-475
Number of pages11
JournalEuropean Journal of Haematology
Volume88
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Hematologic Neoplasms
Peripheral Tolerance
Adaptive Immunity
Immunity
Neoplasms
Theoretical Models
Clinical Trials
Ligands
Therapeutics

Keywords

  • B7-H1
  • Costimulation
  • Leukemia
  • Lymphoma
  • PD-1
  • T cell

ASJC Scopus subject areas

  • Hematology

Cite this

The B7 Homologues and their Receptors in Hematologic Malignancies. / Wilcox, Ryan A.; Ansell, Stephen Maxted; Lim, Megan S.; Zou, Weiping; Chen, Lieping.

In: European Journal of Haematology, Vol. 88, No. 6, 06.2012, p. 465-475.

Research output: Contribution to journalArticle

Wilcox, Ryan A. ; Ansell, Stephen Maxted ; Lim, Megan S. ; Zou, Weiping ; Chen, Lieping. / The B7 Homologues and their Receptors in Hematologic Malignancies. In: European Journal of Haematology. 2012 ; Vol. 88, No. 6. pp. 465-475.
@article{c5342c06d8344cc7a667831a6225bf60,
title = "The B7 Homologues and their Receptors in Hematologic Malignancies",
abstract = "The B7 homologues and their receptors regulate both peripheral tolerance and adaptive immunity. This field is rapidly evolving as new ligands and receptors are being identified. Much of the work supporting their role in the regulation of host anti-tumor immunity has been derived from experimental models and clinical trials in solid malignancies. However, a growing body of evidence demonstrates that the B7-H family has important immunologic and non-immunologic functions in a variety of hematologic malignancies. Herein, we will review recent evidence that supports the therapeutic targeting of the B7 homologues in hematologic malignancies.",
keywords = "B7-H1, Costimulation, Leukemia, Lymphoma, PD-1, T cell",
author = "Wilcox, {Ryan A.} and Ansell, {Stephen Maxted} and Lim, {Megan S.} and Weiping Zou and Lieping Chen",
year = "2012",
month = "6",
doi = "10.1111/j.1600-0609.2012.01766.x",
language = "English (US)",
volume = "88",
pages = "465--475",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - The B7 Homologues and their Receptors in Hematologic Malignancies

AU - Wilcox, Ryan A.

AU - Ansell, Stephen Maxted

AU - Lim, Megan S.

AU - Zou, Weiping

AU - Chen, Lieping

PY - 2012/6

Y1 - 2012/6

N2 - The B7 homologues and their receptors regulate both peripheral tolerance and adaptive immunity. This field is rapidly evolving as new ligands and receptors are being identified. Much of the work supporting their role in the regulation of host anti-tumor immunity has been derived from experimental models and clinical trials in solid malignancies. However, a growing body of evidence demonstrates that the B7-H family has important immunologic and non-immunologic functions in a variety of hematologic malignancies. Herein, we will review recent evidence that supports the therapeutic targeting of the B7 homologues in hematologic malignancies.

AB - The B7 homologues and their receptors regulate both peripheral tolerance and adaptive immunity. This field is rapidly evolving as new ligands and receptors are being identified. Much of the work supporting their role in the regulation of host anti-tumor immunity has been derived from experimental models and clinical trials in solid malignancies. However, a growing body of evidence demonstrates that the B7-H family has important immunologic and non-immunologic functions in a variety of hematologic malignancies. Herein, we will review recent evidence that supports the therapeutic targeting of the B7 homologues in hematologic malignancies.

KW - B7-H1

KW - Costimulation

KW - Leukemia

KW - Lymphoma

KW - PD-1

KW - T cell

UR - http://www.scopus.com/inward/record.url?scp=84862802626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862802626&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0609.2012.01766.x

DO - 10.1111/j.1600-0609.2012.01766.x

M3 - Article

C2 - 22372959

AN - SCOPUS:84862802626

VL - 88

SP - 465

EP - 475

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 6

ER -